Literature DB >> 6015648

Alternative discriminating function for determining hormone dependency of breast cancer.

H Miller, J A Durant, A G Jacobs, J F Allison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6015648      PMCID： PMC1840567          DOI： 10.1136/bmj.1.5533.147

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  A comparison between the urinary steroid excretion of normal women and women with advanced breast cancer.

Authors:  R D BULBROOK; J L HAYWARD; C C SPICER; B S THOMAS
Journal:  Lancet       Date:  1962-12-15       Impact factor: 79.321

2.  A rapid method for measuring 17-hydroxycorticosteroids in urine.

Authors:  M G METCALF
Journal:  J Endocrinol       Date:  1963-06       Impact factor: 4.286

3.  Adrenalectomy and hypophysectomy for advanced cancer of the breast.

Authors:  H J ATKINS; M A FALCONER; J L HAYWARD; K S MACLEAN; P H SCHURR; P ARMITAGE
Journal:  Lancet       Date:  1960-05-28       Impact factor: 79.321

4.  Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone.

Authors:  R D BULBROOK; F C GREENWOOD; J L HAYWARD
Journal:  Lancet       Date:  1960-05-28       Impact factor: 79.321

5.  The analysis of urinary 17-oxo steroids by gradient elution.

Authors:  A E KELLIE; A P WADE
Journal:  Biochem J       Date:  1957-06       Impact factor: 3.857

6.  Indirect analysis of corticosteroids. I. The determination of 17-hydroxycorticosteroids.

Authors:  J I APPLEBY; G GIBSON; J K NORYMBERSKI; R D STUBBS
Journal:  Biochem J       Date:  1955-07       Impact factor: 3.857

7.  The estimation of urinary aetiocholanolone using thin-layer chromatography.

Authors:  H Miller; J A Durant
Journal:  Clin Chim Acta       Date:  1966-10       Impact factor: 3.786
  7 in total
  9 in total

1.  Editorial: Breast cancer and the discriminant.

Authors: 
Journal:  Br Med J       Date:  1975-04-19

2.  Non-specific factors that may influence significance of urinary steroid excretion in breast cancer.

Authors:  J A Durant; H Miller
Journal:  Br Med J       Date:  1973-12-29

3.  Urinary steroid values as a guide to prognosis in breast cancer.

Authors:  K A Ahlquist; A W Jackson; J G Stewart
Journal:  Br Med J       Date:  1968-01-27

4.  Cancer of the breast. Treatment of the advanced disease.

Authors:  J Hayward
Journal:  Br Med J       Date:  1970-05-23

5.  Urinary steroid assays and response to endocrine ablation.

Authors:  B S Thomas; R D Bulbrook; J L Hayward
Journal:  Br Med J       Date:  1967-08-26

6.  Prognosis in breast cancer.

Authors: 
Journal:  Br Med J       Date:  1967-02-25

7.  Benign and malignant breast disease in South Wales: a study of urinary steroids.

Authors:  E H Cameron; K Griffiths; E Gleave; H J Stewart; A P Forrest; H Campbell
Journal:  Br Med J       Date:  1970-12-26

8.  The relationship of urinary and plasma androgens to steroid receptors and menopausal status in breast cancer patients and their influence on survival.

Authors:  B H Mason; I M Holdaway; S J Skinner; R G Kay
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Ratio of 11-desoxy 17-oxosteroids to creatinine in a population screened for breast cancer.

Authors:  J Poortman; J van der Smissen; H J Collette; F de Waard
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.